Why the study?
Depression and coronary heart disease often co-occur, but whether Kai-Xin-San exerts both antidepressive and cardioprotective effects in post-myocardial infarction depression had not been explored.
Does Kai-Xin-San (KXS) improve depression-like behaviors and cardiac function in a rat model of myocardial ischemia with depression?
Population
50 SD rats
Comparison
Control vs MI vs depression vs MI+depression vs MI+depression treated with 370 mg/kg KXS
Design
Randomized animal study
Follow-up
7 weeks
Authors
Loading...
KXS may confer dual benefits in rat MI-depression models; leaves open translation to human CHD with comorbid depression.
Does Kai-Xin-San (KXS) improve depression-like behaviors and cardiac function in a rat model of myocardial ischemia with depression?
KXS demonstrates both antidepressant-like activity and cardioprotective effects in a rat model of post-myocardial infarction depression.
Hu et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: